APIs and Intermediates

Based on our extensive experience and scientific know-how, we have developed a range of pharmaceutical bulk actives and intermediates in several therapeutic categories, principally in oncology and "Anti Retro Virals" (ARVs), and currently have more than 30 actives and intermediates in various stages of development. Aptuit Laurus believes its low cost technologies in the ARV segment will help increase access to medicine for those in need the world over.

With state-of-the-art highly-potent API facilities both at developmental as well as commercial scale, Aptuit Laurus considers Oncology its core competence and offers 18 actives and intermediates in this segment alone.

With proven capabilities of quality, IP and cost, together with a unique range of services from contract development and manufacturing, product development, regulatory filing and registration to long-term contract manufacturing, we have the science, the people and the quality service to provide a total API solution for our global clients.

Please click here to view our product table

Click here for detailed information on our high potent and other manufacturing facilities